USD 169.52
(-1.89%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 81.5 Million USD | -43.21% |
2022 | 143.5 Million USD | -37.5% |
2021 | 229.6 Million USD | -4.45% |
2020 | 240.3 Million USD | 22.47% |
2019 | 196.21 Million USD | 1.38% |
2018 | 193.54 Million USD | 47.05% |
2017 | 131.61 Million USD | -56.23% |
2016 | 300.66 Million USD | 260.94% |
2015 | 83.3 Million USD | 14.87% |
2014 | 72.51 Million USD | 24.22% |
2013 | 58.38 Million USD | -6.25% |
2012 | 62.27 Million USD | -2.24% |
2011 | 63.7 Million USD | -13.37% |
2010 | 73.53 Million USD | 38.14% |
2009 | 53.22 Million USD | 66.72% |
2008 | 31.92 Million USD | -24.44% |
2007 | 42.25 Million USD | -76.76% |
2006 | 181.82 Million USD | 444.7% |
2005 | 33.38 Million USD | 968.62% |
2004 | -3.84 Million USD | 44.26% |
2003 | -6.89 Million USD | -3687.91% |
2002 | -182 Thousand USD | 0.0% |
1999 | -13.5 Million USD | -62.65% |
1998 | -8.3 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q3 | 9.8 Million USD | -38.75% |
2024 Q2 | 16 Million USD | -15.34% |
2024 Q1 | 18.9 Million USD | -44.25% |
2023 Q2 | 15.7 Million USD | -26.29% |
2023 Q1 | 21.3 Million USD | -47.92% |
2023 FY | 81.5 Million USD | -43.21% |
2023 Q4 | 33.9 Million USD | 219.81% |
2023 Q3 | 10.6 Million USD | -32.48% |
2022 Q3 | 37.9 Million USD | 109.39% |
2022 Q2 | 18.1 Million USD | -61.16% |
2022 Q1 | 46.6 Million USD | -31.73% |
2022 Q4 | 40.9 Million USD | 7.92% |
2022 FY | 143.5 Million USD | -37.5% |
2021 FY | 229.6 Million USD | -4.45% |
2021 Q1 | 53.38 Million USD | -24.46% |
2021 Q2 | 50.2 Million USD | -5.96% |
2021 Q3 | 57.8 Million USD | 15.14% |
2021 Q4 | 68.25 Million USD | 18.09% |
2020 Q2 | 55.77 Million USD | -13.47% |
2020 Q1 | 64.45 Million USD | 21.8% |
2020 Q3 | 49.4 Million USD | -11.42% |
2020 Q4 | 70.66 Million USD | 43.04% |
2020 FY | 240.3 Million USD | 22.47% |
2019 Q3 | 49.08 Million USD | 9.35% |
2019 Q1 | 49.32 Million USD | 5.09% |
2019 Q2 | 44.88 Million USD | -8.99% |
2019 FY | 196.21 Million USD | 1.38% |
2019 Q4 | 52.92 Million USD | 7.82% |
2018 Q4 | 46.93 Million USD | -17.84% |
2018 FY | 193.54 Million USD | 47.05% |
2018 Q3 | 57.12 Million USD | 30.27% |
2018 Q1 | 45.63 Million USD | 12299.46% |
2018 Q2 | 43.85 Million USD | -3.89% |
2017 FY | 131.61 Million USD | -56.23% |
2017 Q4 | 368 Thousand USD | -98.97% |
2017 Q3 | 35.85 Million USD | -20.57% |
2017 Q2 | 45.13 Million USD | -12.41% |
2017 Q1 | 51.53 Million USD | -76.06% |
2016 Q3 | 27.77 Million USD | -7.49% |
2016 Q2 | 30.02 Million USD | 8.87% |
2016 Q1 | 27.57 Million USD | 14.42% |
2016 Q4 | 215.29 Million USD | 675.19% |
2016 FY | 300.66 Million USD | 260.94% |
2015 Q3 | 19.32 Million USD | -0.13% |
2015 FY | 83.3 Million USD | 14.87% |
2015 Q4 | 24.1 Million USD | 24.71% |
2015 Q2 | 19.35 Million USD | -5.71% |
2015 Q1 | 20.52 Million USD | -3.29% |
2014 Q2 | 13.8 Million USD | -39.02% |
2014 Q3 | 14.86 Million USD | 7.69% |
2014 Q4 | 21.22 Million USD | 42.78% |
2014 FY | 72.51 Million USD | 24.22% |
2014 Q1 | 22.63 Million USD | 143.02% |
2013 Q3 | 15.6 Million USD | -8.43% |
2013 FY | 58.38 Million USD | -6.25% |
2013 Q1 | 16.42 Million USD | 9.47% |
2013 Q2 | 17.03 Million USD | 3.71% |
2013 Q4 | 9.31 Million USD | -40.31% |
2012 Q4 | 15 Million USD | 8.79% |
2012 Q2 | 17.69 Million USD | 12.19% |
2012 Q1 | 15.77 Million USD | 14.14% |
2012 Q3 | 13.79 Million USD | -22.05% |
2012 FY | 62.27 Million USD | -2.24% |
2011 Q2 | 17.03 Million USD | -5.41% |
2011 Q3 | 14.82 Million USD | -12.97% |
2011 Q4 | 13.82 Million USD | -6.8% |
2011 Q1 | 18.01 Million USD | 11.78% |
2011 FY | 63.7 Million USD | -13.37% |
2010 Q4 | 16.11 Million USD | -1.86% |
2010 Q1 | 26.71 Million USD | 89.97% |
2010 FY | 73.53 Million USD | 38.14% |
2010 Q2 | 14.28 Million USD | -46.51% |
2010 Q3 | 16.41 Million USD | 14.92% |
2009 Q4 | 14.06 Million USD | 7.7% |
2009 Q1 | 13.02 Million USD | 2556.79% |
2009 Q2 | 13.09 Million USD | 0.55% |
2009 Q3 | 13.05 Million USD | -0.28% |
2009 FY | 53.22 Million USD | 66.72% |
2008 Q3 | 13.06 Million USD | 23.24% |
2008 Q4 | -530 Thousand USD | -104.06% |
2008 FY | 31.92 Million USD | -24.44% |
2008 Q2 | 10.6 Million USD | 20.59% |
2008 Q1 | 8.79 Million USD | -21.8% |
2007 Q3 | 10.55 Million USD | -0.06% |
2007 Q4 | 11.24 Million USD | 6.56% |
2007 Q1 | 9.09 Million USD | -26.49% |
2007 FY | 42.25 Million USD | -76.76% |
2007 Q2 | 10.55 Million USD | 16.04% |
2006 Q1 | 144.69 Million USD | 1633.94% |
2006 FY | 181.82 Million USD | 444.7% |
2006 Q3 | 12.37 Million USD | 0.0% |
2006 Q4 | 12.37 Million USD | 0.0% |
2006 Q2 | 12.37 Million USD | -91.45% |
2005 Q1 | 8.34 Million USD | 0.0% |
2005 Q3 | 8.34 Million USD | 0.0% |
2005 FY | 33.38 Million USD | 968.62% |
2005 Q4 | 8.34 Million USD | 0.0% |
2005 Q2 | 8.34 Million USD | 0.0% |
2004 FY | -3.84 Million USD | 44.26% |
2003 FY | -6.89 Million USD | -3687.91% |
2002 FY | -182 Thousand USD | 0.0% |
1999 Q3 | -2.6 Million USD | 0.0% |
1999 Q4 | -4.5 Million USD | -73.08% |
1999 FY | -13.5 Million USD | -62.65% |
1998 FY | -8.3 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Akoya Biosciences, Inc. | -63.32 Million USD | 228.705% |
AngioDynamics, Inc. | -184.34 Million USD | 144.21% |
AtriCure, Inc. | -30.43 Million USD | 367.757% |
Avinger, Inc. | -18.32 Million USD | 544.869% |
Azenta, Inc. | -14.25 Million USD | 671.649% |
BioLife Solutions, Inc. | -66.42 Million USD | 222.691% |
The Cooper Companies, Inc. | 294.2 Million USD | 72.298% |
Daxor Corporation | 280.64 Thousand USD | -28940.764% |
Ekso Bionics Holdings, Inc. | -15.19 Million USD | 636.255% |
Femasys Inc. | -14.24 Million USD | 672.045% |
GlucoTrack, Inc. | -7.09 Million USD | 1248.373% |
Harvard Bioscience, Inc. | -3.41 Million USD | 2486.53% |
Hologic, Inc. | 789.5 Million USD | 89.677% |
ICU Medical, Inc. | -29.65 Million USD | 374.827% |
Intuitive Surgical, Inc. | 1.79 Billion USD | 95.467% |
KORU Medical Systems, Inc. | -13.74 Million USD | 693.113% |
LeMaitre Vascular, Inc. | 30.1 Million USD | -170.719% |
Innovative Eyewear, Inc. | -6.66 Million USD | 1323.094% |
Innovative Eyewear, Inc. | -6.66 Million USD | 1323.094% |
Microbot Medical Inc. | -10.74 Million USD | 858.845% |
Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | -601.05% |
Merit Medical Systems, Inc. | 94.41 Million USD | 13.675% |
Nephros, Inc. | -1.57 Million USD | 5274.603% |
NovoCure Limited | -207.04 Million USD | 139.364% |
NEXGEL, Inc. | -3.15 Million USD | 2681.565% |
NEXGEL, Inc. | -3.15 Million USD | 2681.565% |
Singular Genomics Systems, Inc. | -94.82 Million USD | 185.952% |
OraSure Technologies, Inc. | 53.65 Million USD | -51.896% |
Pro-Dex, Inc. | 2.12 Million USD | -3731.688% |
Pulse Biosciences, Inc. | -42.21 Million USD | 293.082% |
Predictive Oncology Inc. | -13.98 Million USD | 682.81% |
Precision Optics Corporation, Inc. | -2.95 Million USD | 2861.423% |
QuidelOrtho Corporation | -10.1 Million USD | 906.931% |
Repligen Corporation | 41.57 Million USD | -96.022% |
Sanara MedTech Inc. | -4.3 Million USD | 1993.941% |
STAAR Surgical Company | 21.34 Million USD | -281.787% |
Sharps Technology, Inc. | -9.84 Million USD | 928.114% |
Utah Medical Products, Inc. | 16.63 Million USD | -389.931% |
DENTSPLY SIRONA Inc. | -132 Million USD | 161.742% |
Jin Medical International Ltd. | 2.87 Million USD | -2731.601% |